16
Participants
Start Date
November 30, 2013
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
MP-3180
MP-3180 (1 µmol/kg or 0.372 mg/kg) (fluorescent tracer agent) was administered by IV injection (2.5 mL to 3.5 mL for participant weights of 70 kg to 91 kg) over 2 minutes, followed by a 10 mL saline flush IV over 2 minutes.
Iohexol comparator
Iohexol (Omnipaque 300, 5 mL) was administered by IV injection over 2 minutes, followed by a 10 mL saline flush IV over 2 minutes.
University of Maryland, Baltimore
Lead Sponsor
MediBeacon
INDUSTRY